NEWS
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero
Meet the family rewriting the rules of Alzheimer’s disease
Meet the family rewriting the rules of Alzheimer's disease! In her newest Forbes article, Ellen Matloff describes the groundbreaking study identifying potential protective genes for Alzheimer's disease onset. The patient in question carried a mutation in a gene called...
Genetic Testing Challenges in Oncology: Patient Insists on Unnecessary Von Hippel-Lindau Testing
A doctor told a 59-year-old patient that she may have Von Hippel-Lindau syndrome (VHL) due to a personal history of polyps and family history of gastrointestinal cancers. The patient met with a genetic counselor, who determined the patient did not have any features...
Genetic Testing Challenges in Oncology: Karyotype, Germline Clues in Somatic Diagnosis Lost in Translation
A 61-year old Jewish woman with a hematologic malignancy and a family history of breast cancer was referred to genetic counseling. As part of her work-up, the heme-onc had ordered somatic testing of the patient’s blood cancer, which revealed a TP53 variant at a high...
Women Blocked From Meds For Conditions Unrelated To Abortion
After the overturning of Roe v. Wade 1 year ago, women living in states with restrictive abortion laws have struggled to access medication for conditions like Crohns, lupus, and rheumatoid arthritis. Girls and women of childbearing age who are taking methotrexate for...
Genetic Testing Challenges in Oncology: Patient with Pending Bill has BRCA1 Result Withheld
A patient diagnosed with metastatic, poorly differentiated, stage IIIB invasive ductal, triple-negative breast cancer was not given pre- or post-test genetic counseling before undergoing genetic testing. After seeing another surgeon for bilateral mastectomy, the...
Precision Oncology in 2022: New Drugs and Tests Amid Ongoing Access Barriers
In 2022, many new therapies and tests for cancer were approved, but a significant number of patients are still not receiving appropriate therapies. Suboptimal testing paradigms, reimbursement issues and physicians' inability to keep up with rapidly advancing science...
Myriad Genetics (MYGN) To Share Guarded BRCA Variant Information In Public Database
Myriad Genetics is set to share information about guarded BRCA variants in a public database, marking a significant shift in the company's approach to sharing genetic information. Previously, the company had been criticized for guarding such information and limiting...
The Latest Thinking on Genetic Testing
Ellen Matloff sits down with Everyday Health to discuss the past, present, and future of genetic testing. With advances in technology and research, genetic testing is becoming increasingly accessible and informative. However, there are still many misconceptions and...
Genetic Testing Challenges in Oncology: Missed Variant Update Delays Li-Fraumeni Diagnosis
A woman with a history of breast cancer and a family history of pancreatic cancer was diagnosed with Cushing's disease. She was referred to a genetic counselor who found that the patient had a TP53 variant associated with Li-Fraumeni syndrome (LFS) that had been...